Avadel Pharmaceuticals PLC (AVDL)
15.01
+0.03
(+0.20%)
USD |
NASDAQ |
Jun 21, 16:00
15.21
+0.20
(+1.33%)
After-Hours: 20:00
Avadel Pharmaceuticals Cash from Financing (Quarterly): 13.19M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.19M |
| December 31, 2023 | -21.11M |
| September 30, 2023 | 30.46M |
| June 30, 2023 | 91.54M |
| March 31, 2023 | 34.44M |
| December 31, 2022 | 6.622M |
| September 30, 2022 | 10.72M |
| June 30, 2022 | -4.803M |
| March 31, 2022 | 2.009M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.114M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.149M |
| December 31, 2020 | 0.183M |
| September 30, 2020 | -0.016M |
| June 30, 2020 | 117.31M |
| March 31, 2020 | 62.21M |
| December 31, 2019 | -0.041M |
| September 30, 2019 | -0.041M |
| June 30, 2019 | -0.037M |
| March 31, 2019 | 0.092M |
| December 31, 2018 | -0.076M |
| September 30, 2018 | -0.425M |
| June 30, 2018 | -9.755M |
| March 31, 2018 | 122.92M |
| Date | Value |
|---|---|
| December 31, 2017 | -6.026M |
| September 30, 2017 | -3.934M |
| June 30, 2017 | -12.95M |
| March 31, 2017 | -0.406M |
| December 31, 2016 | 0.058M |
| September 30, 2016 | -0.624M |
| June 30, 2016 | -0.409M |
| March 31, 2016 | -6.979M |
| December 31, 2015 | -7.501M |
| September 30, 2015 | -5.378M |
| June 30, 2015 | -10.79M |
| March 31, 2015 | -0.079M |
| December 31, 2014 | 12.93M |
| September 30, 2014 | 2.149M |
| June 30, 2014 | 0.845M |
| March 31, 2014 | 80.07M |
| December 31, 2013 | 3.888M |
| September 30, 2013 | -0.183M |
| June 30, 2013 | 0.247M |
| March 31, 2013 | 14.32M |
| December 31, 2012 | -0.141M |
| September 30, 2012 | 0.687M |
| June 30, 2012 | 5.668M |
| March 31, 2012 | 0.741M |
| December 31, 2011 | 0.14M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-21.11M
Minimum
Dec 2023
117.31M
Maximum
Jun 2020
17.14M
Average
0.166M
Median
Cash from Financing (Quarterly) Benchmarks
| Trinity Biotech PLC | 18.85M |
| Amarin Corp PLC | -1.426M |
| Medtronic PLC | -2.359B |
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics PLC | 1.514M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.70M |
| Cash from Investing (Quarterly) | 21.39M |
| Free Cash Flow | -127.98M |
| Free Cash Flow Per Share (Quarterly) | -0.324 |
| Free Cash Flow to Equity (Quarterly) | -29.70M |
| Free Cash Flow to Firm (Quarterly) | -27.10M |
| Free Cash Flow Yield | -9.79% |